TP53 and cancer: In ≈60% of these cancer types represented by breast cancer (BRCA), intratumor levels of PDCD11 increased on comparing p53‐mutant with p53‐WT, but were unchanged in the other 40% cancer types represented by colon cancer (COAD) (Figure 1A,B; Figure S1, Supporting Information).